LUMIT

Serial Number 79404481
645

Registration Progress

Application Filed
Oct 27, 2023
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

LUMIT

Basic Information

Serial Number
79404481
Filing Date
October 27, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
645
Status Date
Jun 6, 2025
Application
Pending
Classes
005 042

Rights Holder

LuMit Co., Ltd.

03
Address
2-west, 37,
Bongeunsa-ro 24-gil, Gangnam-gu Seoul
KR

Ownership History

LuMit Co., Ltd.

Original Applicant
03
KR

Legal Representation

Attorney
Charles Y. Park

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

18 events
Date Code Type Description Documents
Jun 6, 2025 GNFR O FINAL REFUSAL E-MAILED Loading...
Jun 6, 2025 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jun 6, 2025 CNFR R FINAL REFUSAL WRITTEN Loading...
Mar 11, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 11, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 11, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 11, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 11, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 11, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 19, 2024 RFNT P REFUSAL PROCESSED BY IB Loading...
Sep 27, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Sep 27, 2024 RFRR P REFUSAL PROCESSED BY MPU Loading...
Sep 24, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Sep 23, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 18, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 17, 2024 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Sep 17, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 12, 2024 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical agents affecting peripheral nervous system; dietary fiber to aid digestion; pharmaceutical preparations for the prevention of disorders of the nervous system; cardiovascular pharmaceutical preparations; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of cardiovascular disease; eye drops; allergy medications; dietetic food substances, namely, plant-derived bioactive compounds, mitochondria-targeted supplements, and functional nutraceuticals for cardiovascular, immune, and metabolic health adapted for medical use; bath preparations for medical purposes; diagnostic agents for medical use; slimming tea for medical purposes; pharmaceutical compositions for the prevention and treatment of mitochondrial disorders, metabolic imbalances, cardiovascular diseases, immune dysregulation, cancer, fibrosis, and neurodegenerative diseases; pharmaceutical preparations for enhancing mitochondrial bioenergetics to support cardiovascular function, regulate immune responses, prevent and treat cardiac fibrosis, and improve vascular and metabolic health; pharmaceutical preparations for the treatment of central nervous system (CNS) diseases; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for diagnosis of mitochondrial disorders, cardiovascular diseases, immune dysregulation, cancer progression, neurodegenerative progression, and metabolic imbalances; analgesic balm; nutraceuticals for therapeutic purposes in the nature of mitochondrial energy restoration, immune system modulation, endothelial function support, and fibrosis attenuation; nutraceutical preparations for therapeutic and medical purposes in the nature of cardiovascular protection, oxidative stress regulation, immune system enhancement, and cellular metabolism optimization; pharmaceutical preparations for the treatment of parkinson's disease; antimicrobials for dermatologic use; pharmaceutical preparations for treating epidermal problems; pharmaceutical preparation for skin care; pharmaceutical preparations for skin care; antihypertensives; anti-diabetic pharmaceuticals; anti-cancer preparations; anti-sarcoma preparations; anticoagulants; anti-cancer preparations in the nature of antineoplastics; anti-dermoinfectives; antidotes; antipyretic analgesics; pharmaceutical preparations for the prevention of disorders of the respiratory system; pharmaceutical preparations for the prevention of diseases of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory organs; pharmaceutical preparations in the nature of pharmaceutical compounds for treating respiratory diseases and infections; pharmaceutical products for treating respiratory diseases; inhaled pharmaceutical preparations for the treatment of respiratory diseases and infections; pharmaceutical preparations for treating respiratory diseases and infections.
Class 042
Pharmaceutical drug development services; development of pharmaceutical preparations and medicines; pharmaceutical research and development; Research and development of medicines.

Classification

International Classes
005 042